ArticleAndrology2026
Risk of priapism after dynamic penile Doppler ultrasound: Single-centre experience on a large cohort of patients.
Article in Andrology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- SIEDY Diagnostic Accuracy in Assessing Erectile Dysfunction in Young Men Living With HIV.Andrology · 2026Article
- Association Between Parameters of Penile Doppler Ultrasound and Cardiovascular Risk in Patients with Erectile Dysfunction: A Single-Center Retrospective Study.Journal of clinical medicine · 2026Article
- Risk of priapism after dynamic penile Doppler ultrasound: Single-centre experience on a large cohort of patients.Andrology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectivesTo evaluate the risk of priapism in patients undergoing Dynamic-Penile duplex ultrasound (D-PDU) who were referred to our Unit between January 2022 and December 2023. PATIENTS AND
methodsWe enrolled 292 patients, of whom 268 underwent Dynamic-Penile duplex ultrasound for erectile dysfunction and 24 for Peyronie's disease. The mean age of the patients was 56 ± 12 years, the mean alprostadil dose administered was 9.17 ± 5.59 mcg and the mean erection response was 79.55 ± 19.95%. To evaluate the occurrence of priapism, we considered i) patients who called our phone number within the first hours following the exam; ii) patients who were referred to our Emergency Department within the 24 h following Dynamic-Penile duplex ultrasound; iii) patients who reported to us the occurrence of priapism at subsequent follow-up visit; iv) patients who e-mailed us to report this side effect.
resultsWe found no cases of priapism (0/292 patients, 0%). Therefore, statistical analysis with correlation and regression analysis was not conducted.
conclusionsIn our opinion, the risk of priapism following Dynamic-Penile duplex ultrasound with alprostadil injection might be re-evaluated, as it appears to be a rare and preventable condition.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.